Kodiak Sciences Inc Common Stock (KOD) is a publicly traded Healthcare sector company. As of May 21, 2026, KOD trades at $36.85 with a market cap of $2.19B and a P/E ratio of -8.22. KOD moved +5.11% today. Year to date, KOD is +44.88%; over the trailing twelve months it is +792.12%. Its 52-week range spans $1.92 to $47.84. Analyst consensus is strong buy with an average price target of $62.67. Rallies surfaces KOD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
KOD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KOD recently traded at $36.85. Market cap is $2.19B. P/E ratio is -8.22. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $36.85 |
| Market Cap | $2.19B |
| P/E Ratio | -8.22 |
| EPS | $-4.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.84 |
| 52-Week Low | $1.92 |
| Volume | 211 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-229.97M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-229.97M | $-4.32 |
| 2024 | $0 | $-176.21M | $-3.35 |
| 2023 | $0 | $-260.49M | $-4.97 |
| 2022 | $0 | $-333.82M | $-6.39 |
7 analysts cover KOD: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $62.67.